Is “next-gen” CAR-T the beginning of the end of cancer?
Cancer is a word we all dread to hear yet a cure for the deadly disease has always felt so...
News
Oncology
News
Amplia’s promising cancer and fibrosis drug enters clinical trials
Solid tumours are notoriously difficult to treat. A recently discovered cancer protein could be the reason why. The protein, known...
News
Prescient Therapeutics – Interview with Dr Allen Ebens
In the battle against blood cancer, chimeric antigen receptor T cell (CAR-T) therapy is proving to be a shining light...
News
Prescient Therapeutics adds Peter Mac collaboration to CAR-T focus
Australian listed biotechnology company Prescient Therapeutics (ASX: PTX) today updated the market on progress on one of its personalised cancer...
News
Aussie biotech aims high in race to cure cancer
Every year 45,000 of the most respected professionals in oncology gather at the American Society of Clinical Oncology (ASCO) annual...
News
The biggest breakthrough in cancer research since chemotherapy
Last month, the best and brightest minds in oncology gathered (virtually) for the American Society of Clinical Oncology (ASCO) annual...
News
Prescient Therapeutics signs COVID-19 antiviral research agreement
Clinical stage oncology company Prescient Therapeutics (ASX: PTX) has announced that two of its assets will be used for a...
News
Next Gen CAR-T Platform a Potential Game Changer – Special Report by Independent Investment Research (IIR)
Independent Investment Research (IIR) recently authored a special investment report on pre-clinical oncology company Prescient Therapeutics (ASX: PTX) which gives...
News
Collaboration vs. competition: What happens when the giants team up?
Three hundred years ago, Adam Smith emphasised the importance of competition arguing that the “invisible hand”- the natural driving forces...
News
Successful treatments for cancer have never been more important
It is impossible to overstate the unprecedented disruptions the world is facing with COVID-19. Stock markets have plunged worldwide and...